Gene · 4607
Papers3,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sequencing in over 50,000 cases identifies coding and structural variation underlying atrial fibrillation risk. | Nat Genet | 2025 | 40050430 | PubTator, text mining | PubMed |
| AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy models. | Nat Commun | 2025 | 40038304 | PubTator, text mining | PubMed |
| Heterogeneity of Myocardial Fibrosis Found in Twins With the MYBPC3 Variant Manifesting as Hypertrophic Cardiomyopathy. | Circ Cardiovasc Imaging | 2025 | 40026153 | PubTator, text mining | PubMed |
| Hypertrophic Cardiomyopathy: Genes and Mechanisms. | Front Biosci (Landmark Ed) | 2025 | 40018920 | PubTator, text mining | PubMed |
| Understanding Sex Differences in Hypertrophic Cardiomyopathy Surgery: Insights From a Decade-Long Cohort Study From China. | J Am Heart Assoc | 2025 | 39996456 | PubTator, text mining | PubMed |
| Neural-symbolic hybrid model for myosin complex in cardiac ventriculum decodes structural bases for inheritable heart disease from its genetic encoding. | Arch Biochem Biophys | 2025 | 39892686 | PubTator, text mining | PubMed |
| Genotype-phenotype correlations in hypertrophic cardiomyopathy: Insights from an HCM Center of Excellence. | Curr Probl Cardiol | 2025 | 39890042 | PubTator, text mining | PubMed |
| Sex-Specific Clinical and Genetic Factors Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy. | Circ Genom Precis Med | 2025 | 39851041 | PubTator, text mining | PubMed |
| Computational analysis of congenital heart disease associated SNPs: unveiling their impact on the gene regulatory system. | BMC Genomics | 2025 | 39838281 | PubTator, text mining | PubMed |
| [Hypertrophic cardiomyopathy with left ventricular excessive trabeculation resulting from MYBPC3 gene mutation: a case report]. | Zhonghua Xin Xue Guan Bing Za Zhi | 2025 | 39806904 | PubTator, text mining | PubMed |
| Hypertrophic cardiomyopathy: insights into pathophysiology and novel therapeutic strategies from clinical studies. | Egypt Heart J | 2025 | 39776022 | PubTator, text mining | PubMed |
| The impact of common and rare genetic variants on bradyarrhythmia development. | Nat Genet | 2025 | 39747593 | PubTator, text mining | PubMed |
| Early genetic screening and cardiac intervention in patients with cardiomyopathies in a multidisciplinary clinic. | ESC Heart Fail | 2025 | 39740200 | PubTator, text mining | PubMed |
| Single Cell Transcriptomic Profiling of MYBPC3-Associated Hypertrophic Cardiomyopathy Across Species Reveals Conservation of Biological Process But Not Gene Expression. | J Am Heart Assoc | 2025 | 39719426 | PubTator, text mining | PubMed |
| Endpoint Selection in Randomized Clinical Trials for Hypertrophic Cardiomyopathy. | JACC Heart Fail | 2025 | 39708028 | PubTator, text mining | PubMed |
| Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy. | Circulation | 2025 | 39633578 | PubTator, text mining | PubMed |
| Unique Genetic Profiles in Hypertrophic Cardiomyopathy Patients From São Miguel Island (Azores, Portugal). | Clin Genet | 2025 | 39605252 | PubTator, text mining | PubMed |
| Genetic Testing Practices and Pathological Assessments in Patients With End-stage Heart Failure Undergoing Heart Transplantation and Left Ventricular Assist Device Use. | J Card Fail | 2025 | 39454940 | PubTator, text mining | PubMed |
| Atrial cardiomyopathy resulting from loss of plakophilin-2 expression: Response to adrenergic stimulation and implications for the exercise response. | J Physiol | 2025 | 39446303 | PubTator, text mining | PubMed |
| Reanalysis of Next-generation Sequencing Data in Patients With Hypertrophic Cardiomyopathy: Contribution of Spliceogenic MYBPC3 Variants in an Italian Cohort. | Ann Lab Med | 2025 | 39355877 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/papers?page=11